Found 5 matching trials
Signatera Assessment in Early-Stage Endometrial Cancer NA The goal of this clinical trial is to assess if circulating tumor DNA can g...
Show More Location
University of Alabama at Birmingham Hospital
Learn More & Join Trial
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer NA The purpose of this study is to evaluate the efficacy and safety of ctDNA-g...
Show More Location
Mayo Clinic Arizona
Learn More & Join Trial
ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and Relatlimab PHASE2 The purpose of this study is to investigate the use of ctDNA measurements t...
Show More Location
NYU Langone Health
Learn More & Join Trial
A Multicenter Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors. NA This is a multicenter, open-label, randomized (1:1) trial designed to evalu...
Show More Location
Multiple Locations
Learn More & Join Trial
Signatera-Guided De-escalation of Adjuvant Therapy in Resectable Stage II-IVa Gastric/Gastric-Esophageal Cancer NA The goal of this clinical trial is to assess if circulating tumor DNA, as a...
Show More Location
Multiple Locations
Learn More & Join Trial